|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net income | |||||
| Adjustments to reconcile net income to cash flows provided by operating activities: | |||||
| Income from equity method investments | |||||
| Amortization | |||||
| Depreciation | |||||
| Prepaid and deferred compensation expense | |||||
| Non-cash equity-based compensation | |||||
| Amortization of debt issuance costs | |||||
| Amortization of interest rate cap premium | |||||
| Deferred income tax expense | |||||
| Deferred income tax expense from common control reorganizations | |||||
| Loss on extinguishment of existing debt | |||||
| Loss (gain) on Tax Receivable Agreement | |||||
| Changes in operating assets and liabilities, net of acquisitions: | |||||
| Commissions and fees receivable – net | |||||
| Accrued interest liability | |||||
| Other current assets and accrued liabilities | |||||
| Other non-current assets and accrued liabilities | |||||
| Other current and non-current assets | |||||
| Other current and non-current liabilities | |||||
| Total cash flows provided by operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Business combinations – net of cash acquired and cash held in a fiduciary capacity | |||||
| Capital expenditures | |||||
| Equity method investment in VSIC | |||||
| Asset acquisitions | |||||
| Repayments of prepaid incentives | |||||
| Total cash flows used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Proceeds from Senior Secured Notes | |||||
| Borrowings on Revolving Credit Facility | |||||
| Repayments on Revolving Credit Facility | |||||
| Debt issuance costs paid | |||||
| Proceeds from term debt | |||||
| Repayment of term debt | |||||
| Payment of interest rate cap premium, net | |||||
| Receipt of contingently returnable consideration | |||||
| Payment of contingent consideration | |||||
| Purchase of remaining interest in Ryan Re | |||||
| Repurchase of preferred equity | |||||
| Equity repurchases from pre-IPO unitholders | |||||
| Total equity repurchases from pre-IPO unitholders | |||||
| Repurchase of pre-IPO LLC Units and payment of Alternative TRA Payments | |||||
| Repayments of unsecured promissory notes | |||||
| Tax distributions to non-controlling LLC Unitholders | |||||
| Receipt of taxes related to net share settlement of equity awards | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Payment of Tax Receivable Agreement liabilities | |||||
| Class A common stock dividends and Dividend Equivalents paid | |||||
| Distributions to non-controlling LLC Unitholders | |||||
| Finance lease and other costs paid | |||||
| Distributions and Declared Distributions paid to non-controlling LLC Unitholders | |||||
| Payments related to Ryan Re preferred units | |||||
| Net change in fiduciary liabilities | |||||
| Total cash flows provided by (used in) financing activities | |||||
| Effect of changes in foreign exchange rates on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | |||||
| NET CHANGE IN CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY | |||||
| Cash and cash equivalents | |||||
| CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY—Beginning balance | |||||
| CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY—Ending balance | |||||
| Reconciliation of cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | |||||
| Interest and financing costs | |||||
| Members' Tax Distributions declared but unpaid | |||||
| Contingent consideration liabilities from business combinations | |||||
| Common stock issued | |||||
| Common Class B | |||||
| Cash and cash equivalents | |||||
| Cash and cash equivalents held in a fiduciary capacity | |||||
Loading...